Skip to main content

Herbal Extract

Mitidol® (Ginger & Acmella Phytosome®)

Also known as: Zingiber officinale CO2 extract, Acmella oleracea extract, Ginger acmella phytosome, Spilanthol ginger complex

C
Evidence

Mitidol® combines standardized ginger rhizome extract (2.4% gingerols and shogaols) with Acmella oleracea (0.3% spilanthol) in a phytosome delivery system designed to enhance bioavailability. The combination targets inflammatory response and oral sensory stimulation, though evidence is primarily derived from individual component research rather than the proprietary blend itself.

Primary uses

  • Anti-inflammatory support
  • Digestive comfort
  • Oral sensory stimulation
  • General wellness

How it works

  • Gingerols and shogaols inhibit prostaglandin and leukotriene synthesis
  • Spilanthol provides localized oral stimulation and potential immune modulation
  • Phytosome delivery enhances absorption and cellular uptake

Dosage

Typical range
As directed by manufacturer; typically 1-2 capsules daily
Timing
With meals for optimal absorption and reduced gastrointestinal upset
With food
Recommended with food to enhance phytosome absorption
Duration
Safe for long-term use; effects typically emerge after 2-4 weeks of consistent use
Special populations
Pregnant/nursing women should consult healthcare provider; may interact with blood thinners or medications metabolized via CYP3A4

Forms

  • Capsule· 70/100

Safety

Common side effects

  • Mild gastrointestinal discomfort (ginger-related)
  • Oral numbness or tingling (acmella-related)

Contraindications

  • Bleeding disorders or anticoagulant therapy (ginger may potentiate effects)
  • Gallstones or bile duct obstruction (ginger contraindication)
  • Pregnancy and lactation (insufficient safety data for proprietary blend)
  • Allergy to Zingiberaceae or Asteraceae families

Evidence notes

Ginger alone has B-grade evidence for anti-inflammatory effects, but the proprietary Mitidol® blend combining ginger phytosome with Acmella lacks dedicated human clinical trials. Acmella oleracea has limited human data. The specific combination and phytosome formulation represent a novel product with preliminary evidence at best.

Grade C: Mostly observational or small trials; mechanism is plausible but unproven at scale.

Related in Herbal Extract

Check a full stack

Formulate's free interaction checker lets you paste in any combination of supplements and medications at once — every pairing flags severity, timing, and cited evidence.

Open the checker

Medical disclaimer. This page is educational and does not replace advice from a qualified healthcare provider.